Hoth Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
NV
Business Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
Mailing Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
Phone
(646)756-2997
Fiscal Year End
1231
EIN
821553794
Financial Overview
FY2025
$7.71M
Total Assets
$7.04M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 2, 2026 | View on SEC |
| 424B5 Prospectus supplement | April 2, 2026 | View on SEC |
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 8-K Current report of material events | January 16, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | November 17, 2025 | View on SEC |
| 424B5 Prospectus supplement | November 13, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 17, 2025 | View on SEC |
| 8-K Current report of material events | September 12, 2025 | View on SEC |
| 4 Insider stock transaction report | August 28, 2025 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Diverse pipeline targeting high-growth areas including Alzheimer’s, dermatology, and weight management.
- Expansion of HT-001 clinical trials into the European market.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.